Pulmonary mycobacterium avium complex infection in HIV-infected patient after immune reconstitution with highly active antiretroviral therapy

Infectious Diseases in Clinical Practice

Volumn 12, Issue 3, 2004, Pages 171-173

  Ofotokun, Ighovwerha ^a   Buch, Ketan P ^b   Lee, Eun Young ^b   Hoven, Ardis ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; LAMIVUDINE PLUS ZIDOVUDINE; LEVOFLOXACIN; NEVIRAPINE; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LABORATORY TEST; LUNG INFECTION; LYMPHADENITIS; LYMPHOCYTE COUNT; MYCOBACTERIUM AVIUM; PNEUMOCYSTOSIS; SPUTUM CULTURE; THORAX RADIOGRAPHY;

EID: 2542503430     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000129849.26885.8c     Document Type: Article

References (33)

1. Wolinsky E. Nontuberculous mycobacterium and associated diseases. Am Rev Respir Dis. 1997;119:107-159.
2. Indelied CB, Kemper CA, Bermudez LE. The Mycobacterium avium complex. Clin Microbiol Rev. 1993;6:266-310.
3. Benson CA. Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment. AIDS Clin Rev. 1997-98;271-287.
4. Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis. 1968;97:1032-1037.
5. Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev. 1996;9177-9215.
6. Chin DP, Hopewell PC, Yajko DM, et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis. 1994;169:289-295.
7. von Reyn CF, Barber TW, Arbeit RD, et al. Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis. 1993;168:1553-1558.
8. Mazurek GH, Chin DP, Harman S, et al. Genetic similarity among Mycobacterium avium isolate from blood, stool, and sputum of persons with AIDS. J Infect Dis. 1997;176:976-983.
9. Corpe RF. Clinical aspects, medical and surgical, in the management of Battey-type pulmonary disease. Dis Chest. 1964;45:380-382.
10. Yeager HJ, Raleigh JW. Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis. 1973;108:547-552.
11. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321:863-868.
12. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern: the Lady Windermere syndrome. Chest. 1992;101(6):1605-1609.
13. Rickman OB, Ryu JH, Fidler ME, et al. Hypersensitivity pneumonia associated with Mycobacterium avium complex and hot tub use. Mayo Clin Proc. 2002;77:1233-1237.
14. Khoor A, Leslie KO, Tazelaar HD, et al. Diffuse pulmonary disease by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol. 2001;115:755-762.
15. Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advance HIV-1 disease. Lancet. 1998;351:252-255.
16. Dworkin MS, Fratkin MD. Mycobacterium avium complex lymph node abscess after use of highly active antiretroviral therapy in a patient with AIDS. Arch Intern Med. 1998;158:1828.
17. Phillips P, Kwiatkowski MB, Copland M, et al. Mycobacterial lymphadenitis with the initiation of combination antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:122-128.
18. DiPerri G, Bonora S, Vento S, et al. Highly active antiretroviral therapy [letter]. Lancet. 1998;351:1056.
19. Cabie A, Abel S, Brebion A, et al. Mycobacterial lymphadenitis after initiation of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 1998;17:812-813.
20. French M, Lenzo N, John M, et al. Immune restoration disease after treatment of immunodeficient HIV infected patients with potent antiretroviral therapy [abstract 22323]. In: Conference Record of the 12th International AIDS Conference (Geneva, Switzerland). Geneva: Marathon Multimedia, 1998.
21. + cell count. Ann Intern Med. 2002;133:493-503.
22. del Giudice PD, Durant J, Counillon E, et al. Mycobacterium cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch Dermatol. 1999;135:1129-1130.
23. Brown M, Williams IG, Miller RF. Deterioration of disseminated cutaneous Mycobacterium avium complex infection with a leukemoid reaction following institution of highly active antiretroviral therapy. Sex Transm Infect. 2001;77:149-150.
24. Murray R, Mallal S, Heath C, et al. Cerebral Mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated Mycobacterium avium complex infection. Eur J Clin Microbiol Infect Dis. 2001;20:199-201.
25. Bartley PB, Allworth AM, Eisen DP. Mycobacterium avium complex causing endobronchial disease in AIDS patients after partial immune restoration. Int J Tuberc Lung Dis. 1999;3:1132-1136.
26. Thaker H, Ong ELC. Localized Mycobacterium avium complex infection in a patient on HAART. Clin Microbiol Infect. 2002;6(10):564-566.
27. Diagnosis and treatment of disease caused by nontuberculosis mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997;156:S1-S25.
28. Li TS, Tubiana R, Katlama C, et al. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advance HIV-1 disease. Lancet. 1998;351:1682-1686.
29. Wendland T, Furrer H, Vemazza PL, et al. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viremia. AIDS. 1999;13:1857-1862.
30. Foudraine NA, Hovenkamp E, Notermans DW, et al. Immunopathology as a result oh highly active antiretroviral therapy in HIV-1 infected patients. AIDS. 1999;13:177-184.
31. Connick E, Lederman MM, Kotzin BL, et al. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis. 2000;181:353-363.
32. + T-cell numbers, and epidermal Langerhans cell density are independent variables. Clin Immunol Immunopathol. 1990;55:86-96.
33. + counts. J Clin Microbiol Infect Dis. 2001;20:889-891.